期刊文献+

比索洛尔对左心室射血分数保留的心力衰竭患者神经内分泌因子的影响 被引量:13

Effects of bisoprolol on neuroendocrine hormones in patients with heart failure with preserved left ventricular ejection fraction
分享 导出
摘要 目的探讨左心室射血分数保留的心力衰竭(HFPEF)患者在接受常规治疗的基础上加用比索洛尔治疗对神经内分泌因子的影响。方法将51例左心室射血分数保留的心力衰竭患者随机分为对照组25例和试验组26例。对照组予以血管紧张素转化酶抑制剂或血管紧张素Ⅱ受体拮抗剂、醛固酮受体拮抗剂、利尿剂等药物联合治疗;试验组在对照组的基础上,加用比索洛尔5~10mg·d^-1,2组疗程均为2周。比较2组治疗前、治疗后第14天的B型尿钠肽、心房钠尿肽、瘦素、嗜铬粒蛋白A、白细胞介素-6、血栓素B2、肿瘤坏死因子α、内皮素、高敏C反应蛋白等神经内分泌因子水平的变化,以及不良反应发生率。结果试验组总有效率88.46%显著高于对照组60.00%(P〈0.05)。与治疗前比较,治疗后2组的B型尿钠肽、心房钠尿肽、瘦素、嗜铬粒蛋白A、内皮素、高敏C反应蛋白水平明显下降(P〈0.05)。治疗后,试验组血浆B型尿钠肽、瘦素、嗜铬粒蛋白A、内皮素、高敏C反应蛋白水平与对照组比较差异有统计学意义(P〈0.05)。2组不良反应发生率比较差异无统计学意义(P〉0.05)。结论左心室射血分数保留的心力衰竭患者在常规治疗基础上加用比索洛尔辅助治疗,可明显改善心功能和神经内分泌因子水平。 Objective To explore the effects of bisoprolol adding to the conventional therapy on neuroendocrine hormones in patients with heart failure with preserved left ventricular ejection fraction (HFPEF). Methods Fifty - one patients with HFPEF were randomly assigned into two groups: control group (n =25) and trial group (n =26). The control group was treated with angiotensin -converting enzyme inhibitors or angiotensin II receptor antagonist and aldosterone receptor antagonists, diuretics and other drugs combination therapy. The trial group was the control group plus bisoprolol 5 - 10 mg · d^-1. Each group was two weeks. The levels of brain natriuretic peptide (BNP) , atrial natriuretic peptide (ANP), leptin, ehromogranin A (CGA), intedeukin- 6 (IL-6), thromhoxane B2 ( TXB2 ), tumor necrosis factor - α(TNF-α), endothelin (ET), hypersensitive C-reactive protein (hs- CRP) were observed fourteen days before and after the treatments, and the incidence rate of adverse drug reactions. Results The total efficiency of the trial group was 88.46% significantly higher than 60. 00% in the control group ( P 〈 0. 05). The levels of plasma BNP, ANP, leptin, CGA, ET, hs - CRP were significantly decreased in the trial group ( P 〈 0. 05 ) after treatment. The levels of plasma BNP, ANP, Leptin, CGA, hs - CRP were significantly decreased in the control group (P 〈 0.05) after treatment. The levels of BNP, leptin, CGA, ET, hs - CRP lower in trial group than in the control group (P 〈 O. 05 ). The incidence rate of adverse drug reactions were not statistical difference between the two groups ( P 〉 0. 05). Conclusion Bisoprolol adding to the convertional therapy can significantly improve the heart function of patients with HFPEF and can lead to more decrease of BNP, leptin, CGA, ET, hs - CRP than the conventional therapy.
作者 甄宇治 邓彦东 李立卓 战吟戈 刘超 刘刚 刘坤申 ZHEN Yu - zhi, DENG Yah - dong, LI Li-zhuo, ZHAN Yin-ge, LIU Chao, LIU Gang, LIU Kun - shen(1. a. Department of Cardiology; b. Ultrasonography, the First Hospital of Hebei Medical University, Shifiazhuang 050031, China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2015年第15期1471-1474,共4页 The Chinese Journal of Clinical Pharmacology
基金 河北省卫生厅指令性课题基金资助项目(20130278)
关键词 比索洛尔 左心室射血分数保留的心力衰竭 神经内分泌因子 瘦素 嗜铬粒蛋白A bisoprolol heart failure with preserved left ventricular ejection fraction neuroendocrine hormones leptin chromogranin A
作者简介 甄宁治(1977-),男,副主任医师,副教授,主要从事心力衰竭、冠心病研究 通信作者:刘坤申,主任医师,教授,博士生导师MP:1863388957E—mail:75647188@qq.com
  • 相关文献

参考文献8

  • 1中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014(2):98-122. 被引量:2399
  • 2Shah AM, Mann DL. In search of new therapeutic targets and strategies for heart failure recent advances in basic ience [ J ]. Lancet, 2011, 378:704 -712. 被引量:1
  • 3Iwanaga Y, Nishi I, Furuichi S, et al. B - type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure[ J ]. J Am Coll Cardiol, 2006,47:742 -748. 被引量:1
  • 4Smith PM, Ferguson AV. Cardiovascular aions of leptin in the subfomi- cal organ are abolished by diet -induced obesity [J ]. J Neuroendocrinol, 2011,24:504 -510. 被引量:1
  • 5Selthofer - Relatic K, Radic R, Vizjak V, et al. Hyperleptinemia - non - haemodynamic risk factor for the left ventricular hypertrophy development in hypertensive overweight females [ J ]. Coil Antropol, 2008,32:681 - 685. 被引量:1
  • 6Jansson AM, Rosjo H, Omland T, et al. Evaluation of predictive value of circulating ehromogranin : A levels in the long - term progno- sis in patients with acute coronary syndrome[ J]. Ear Heart J, 2009, 30:25 - 32. 被引量:1
  • 7Wang W, ANG YL. Cytokines and hert failure [ J ]. J Appl Clin Pe- diatr, 2007,22:1021 - 1023. 被引量:1
  • 8Shimpo M, Morrow DA, Weinberg EO, et al. Serum levels of the in- terleukin - 1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction [ J ]. Circulation, 2004,109 :2186 -2190. 被引量:1

二级参考文献145

  • 1中华医学会心血管病学分会.中国部分地区1980、1990、2000年慢性心力衰竭住院病例同顾性调查[J]中华心血管病杂志,2002,30:450-454. 被引量:1
  • 2McMurray JJ.Clinical practice.Systolic heart failure[J].N Engl J Med,2010,362:228-238. 被引量:1
  • 3Shah AM,Mann DL.In search of new therapeutic targets and strategies for heart failure:recent advances in basic science[J].Lancet,2011,378:704-712. 被引量:1
  • 4Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failing):developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation:endorsed by the Heart Rhythm Society[J].Circulation,2005,112:e154-e235. 被引量:1
  • 5Jessup M,Abraham WT,Casey DE,et al.2009 focused update:ACCF/AHA guidelines for the diagnosis and management of heart failure in adults:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines:developed in collaboration with the International Society for Heart and Lung Transplantation[J].Circulation,2009,119:1977-2016. 被引量:1
  • 6Dunlay SM,Redfield MM,Weston SA,et al.Hospitalizations after heart failure diagnosis a community perspective[J].J Am Coll Cardiol,2009,54:1695-1702. 被引量:1
  • 7Troughton RW,Frampton CM,Yandle TG,et al.Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations[J].Lancet,2000,355:1126-1130. 被引量:1
  • 8Pfisterer M,Buser P,Rickli H,et al.BNP-guided vs symptom-guided heart failure therapy:the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial[J].JAMA,2009,301:383-392. 被引量:1
  • 9Lainchbury JG,Troughton RW,Strangman KM,et al.N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure:results from the BATTLESCARRED (NT-proBNP-assisted treatment to lessen serial cardiac readmissions and death) trial[J].J Am Coll Cardiol,2009,55:53-60. 被引量:1
  • 10Porapakkham P,Porapakkham P,Zimmet H,et al.B-type natriuretic peptide-guided heart failure therapy:a meta-analysis[J].Arch Intern Med,2010,170:507-514. 被引量:1

共引文献2398

同被引文献114

引证文献13

二级引证文献18

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈